Russell Investments Group
ARRY

Russell Investments Group’s Array Biopharma Inc ARRY Stock Holding History

Russell Investments Group’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-268,659
Closed -$12.4M – 3171
2019
Q2 		$12.4M Sell
268,659
-165,449
-38% -$4.65M 0.02% 769
2019
Q1 		$10.6M Buy
434,108
+360,739
+492% +$7.51M 0.02% 872
2018
Q4 		$1.04M Buy
73,369
+2,525
+4% +$38.3K ﹤0.01% 1932
2018
Q3 		$1.08M Buy
70,844
+34,016
+92% +$521K ﹤0.01% 2079
2018
Q2 		$618K Sell
36,828
-43,347
-54% -$690K ﹤0.01% 2321
2018
Q1 		$1.31M Sell
80,175
-70,359
-47% -$1.13M ﹤0.01% 2081
2017
Q4 		$1.95M Sell
150,534
-25,840
-15% -$294K ﹤0.01% 1827
2017
Q3 		$2.17M Buy
176,374
+19,334
+12% +$180K ﹤0.01% 1741
2017
Q2 		$1.31M Buy
157,040
+25,118
+19% +$205K ﹤0.01% 1976
2017
Q1 		$1.18M Buy
131,922
+60,527
+85% +$644K ﹤0.01% 2011
2016
Q4 		$619K Buy
+71,395
New +$525K ﹤0.01% 2390

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Russell Investments Group's ARRY Position: Q3 2019 in Review

Russell Investments Group sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 268,659 shares — an estimated $12.4M sold.

Russell Investments Group first reported a position in ARRY in Q4 2016 and held it in 11 quarters. The position peaked at $12.4M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Russell Investments Group reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Russell Investments Group sold 268,659 Array Biopharma Inc shares in Q3 2019, an estimated $12.4M.
  • Russell Investments Group first reported a position in Array Biopharma Inc in Q4 2016 and held it in 11 quarters.
  • Russell Investments Group's Array Biopharma Inc position peaked at $12.4M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Russell Investments Group's 13F filing for Q3 2019, filed 1 Nov 2019.